|
Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization |
Micallef IN, Sinha S, Gastineau DA, Wolf R, Inwards DJ, Gertz MA, Hayman SR, Hogan WJ, Johnston PB, Lacy MQ, Ansell SM, Buadi F, Dingli D, Dispenzieri A, Litzow MR, Porrata LF, Winters JL, Kumar S |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Micallef IN, Sinha S, Gastineau DA, Wolf R, Inwards DJ, Gertz MA, Hayman SR, Hogan WJ, Johnston PB, Lacy MQ, Ansell SM, Buadi F, Dingli D, Dispenzieri A, Litzow MR, Porrata LF, Winters JL, Kumar S. Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization. Biology of Blood and Marrow Transplantation 2013; 19(1): 87-93 Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; Algorithms; Case-Control Studies; Costs and Cost Analysis; Female; Hematopoietic Stem Cell Mobilization /economics /methods; Heterocyclic Compounds /administration & Humans; Lymphoma, Non-Hodgkin /economics /therapy; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation /economics; Plasmacytoma /economics /therapy; Risk Factors; Time Factors; Transplantation, Autologous; dosage /adverse effects /economics AccessionNumber 22013004278 Date bibliographic record published 28/02/2013 |
|
|
|